Company intelligence
Sequentia Biotech
Bringing omics to life
About Sequentia Biotech
Sequentia Biotech, an innovative bioinformatics firm, has been at the forefront of genomics since its establishment in 2013. Renowned for its cutting-edge solutions, Sequentia excels in providing comprehensive bioinformatics and software solutions across a spectrum of fields, including diagnostics, drug discovery, medical and academic research, plant biology, and food technologies. With a remarkable 15 years of experience in bioinformatics and significant investments in Research and Development (R&D), Sequentia has successfully completed over 700 bioinformatics projects. Serving clients in 63 countries, the company has contributed to over 70 publications in esteemed journals, showcasing an impressive H-index of 130. This outstanding track record underscores Sequentia's commitment to excellence. The company's overarching vision is to foster innovation and introduce disruptive technologies in the biotechnology landscape. By leveraging the potential of omics sciences, Sequentia aims to make meaningful contributions to society. Partner with Sequentia as they strive to shape a future where global advancements in biotechnology have a positive and transformative impact on lives.
Verified activity
Signals from Sequentia Biotech
7 published signals
Research & Knowledge
Sequentia Biotech published a study in Nature Communications that sequenced urban wastewater across an entire city to reveal antibiotic resistance genes circulate through residential pipelines, treatment plants, and samples linked to international flights.
Reported by Walter Sanseverino
Partnerships
Sequentia Biotech partnered with the University of Navarra to support students in their Master’s in Biomedical Research (Biotecnología Biomédica) specialization, offering hands-on experience using BatchX for practical sessions on Omics Technologies for Biomedical Research and Precision Medicine.
Reported by Sequentia Biotech
Research & Knowledge
Sequentia Biotech performed a benchmarking study to test how GAIA performed against 12 taxonomic classifiers including Kraken2, MEGAN-LR, BugSeq, and Sourmash against PacBio HiFi and Oxford Nanopore Technologies (ONT) long-read datasets.
Reported by Walter Sanseverino
Research & Knowledge
Sequentia Biotech published the Global Microbiome Conservancy, an effort by MIT researchers Mathilde Poyet and Mathieu Groussin to collect microbiome samples from communities worldwide.
Reported by Walter Sanseverino
Presence & Recognition
Sequentia Biotech is attending the XII Congreso Nacional de Mejora Genética de Plantas in Málaga from September 28 to October 1, hosted by Sociedad Española de Ciencias Hortícolas and Sociedad Española de Genética (SEG).
Reported by Sequentia Biotech
Products & Services
Sequentia Biotech launched SABIO, a genome safety platform built for EFSA 2025 compliance, QPS approval, and Novel Foods authorisation.
Reported by Walter Sanseverino
Legal & Regulatory
Sequentia Biotech received CE-IVDR certification for MICK Clinical, a cloud software supporting laboratories and healthcare institutions for efficient screening of selected gastrointestinal microorganisms.
Reported by Walter Sanseverino